All articles by Amit Thadani
Amit Thadani
GSK’s RSV vaccine for older adults shows positive outcomes in Phase 3 trial
The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults aged 60 years and above
Amylyx secures Health Canada approval for Albrioza to treat ALS
Albrioza, also known as AMX0035, is an oral fixed-dose combination therapy that works to reduce neuronal cell death and is the first new ALS therapy approved in Canada since 2018
Massachusetts authorities confirm first case of monkeypox in US
The US Centres for Disease Control and Prevention (CDC) has confirmed the first monkeypox infection, after conducting a confirmatory test
Weaponising data to fight infection in hospitals
Healthcare-associated infections are one of the greatest preventable threats to patient safety. In addition to causing suffering, they can do lasting, economic damage to medical facilities. The annual estimated costs in Europe amount to over €7bn. The HARTMANN GROUP has launched a new initiative to improve the position of hospitals in the important fight against healthcare-associated infections.
Laser photobiomodulation for faster healing and pain management
Light therapy has been increasingly used for a wide variety of medical applications. However, treatments for wound healing and pain management are the most commonly used applications and form the basis for the most clinical evidence supporting the positive effects of light therapy. Fotona’s handpieces offer this revolutionary, non-invasive solution in a number of spot sizes and wavelengths.
Battling the resistance
Abbott is an expert in the use of rapid diagnostics to help combat antimicrobial resistance globally, and has a refined understanding of the role education plays in enabling the widespread adoption of C-reactive protein point-of-care testing.
Putting antibiotic resistance to the test
Just like other organisms, disease-causing bacteria evolve defence mechanisms that allow it to survive when patients are treated with antibiotics. A liberal approach to prescribing them is part of the issue because repeated exposure provides the stimulus for evolutionary adaptation. Felicia Longobardi, leader of EMEA rapid diagnostics at Abbott outlines the scale of the issue and explains how point-of-care diagnostic testing can help healthcare professionals avoid overprescribing antibiotics.
Embracing preanalytics for better diagnostics
When swabbing became an all-too-familiar experience, testing and screening were understood as vital processes in the fight against viral infection. Sampling was identified as a crucial stage, and the world came to know the importance of preanalytics. Copan’s pioneering solution covers all facets of the preanalytical stage, accompanying any sample to improved diagnostics.
Complete test portfolio for Lyme disease diagnostics
A comprehensive portfolio of Borrelia antibody test systems from EUROIMMUN enables qualified two-step Lyme disease diagnostics according to the latest recommendations. Screening and confirmatory tests based on optimised combinations of native and recombinant antigens are complemented by flexible automation options for all tests and throughput requirements.
A rapid response to the pandemic
As the world continues to deal with Covid-19, quick and accurate testing is still one of the best ways to slow its spread and protect the most vulnerable in our communities. Colleen Monaghan PhD, product manager at Bruker, explains how its range of SARS-CoV-2 assays provide reliable testing for recent mutations, to identify infection and defend against the virus.